Hong Ling, n/a

Nanjing Leads Biolabs Co., Ltd.
Nan Jing, China (People's Republic)

Presentation(s):

• 0005: LBL-047, A First-In-Class Anti-BDCA2/TACI Fusion Protein, Inhibits the Function of Both pDCs and B cells

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.

• 0986: LBL-053, A Novel Anti-TL1A/p40 Bispecific Antibody for the Treatment of Autoimmune Disorders.

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.